NCM
Nantahala Capital Management’s Abeona Therapeutics ABEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Buy |
4,369,665
+859,815
| +24% | +$4.88M | 0.97% | 13 |
|
|
2025
Q1 | $16.7M | Sell |
3,509,850
-19,364
| -0.5% | -$92.2K | 0.66% | 16 |
|
|
2024
Q4 | $19.7M | Buy |
3,529,214
+96,577
| +3% | +$538K | 0.84% | 19 |
|
|
2024
Q3 | $21.7M | Sell |
3,432,637
-37,400
| -1% | -$236K | 1.1% | 14 |
|
|
2024
Q2 | $14.7M | Buy |
3,470,037
+1,159,397
| +50% | +$4.92M | 0.86% | 14 |
|
|
2024
Q1 | $16.8M | Buy |
2,310,640
+60,388
| +3% | +$438K | 0.96% | 14 |
|
|
2023
Q4 | $11.3M | Sell |
2,250,252
-47,542
| -2% | -$238K | 0.67% | 27 |
|
|
2023
Q3 | $9.67M | Buy |
2,297,794
+895,914
| +64% | +$3.77M | 0.83% | 23 |
|
|
2023
Q2 | $5.65M | Sell |
1,401,880
-26,795
| -2% | -$108K | 0.55% | 39 |
|
|
2023
Q1 | $4.03M | Buy |
1,428,675
+1,155,944
| +424% | +$3.26M | 0.31% | 48 |
|
|
2022
Q4 | $4.19M | Buy |
+272,731
| New | +$4.19M | 0.27% | 44 |
|